Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H14N2O2.C2H4O2 |
Molecular Weight | 206.2395 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)=O.NCCCC[C@H](N)C(O)=O
InChI
InChIKey=RRNJROHIFSLGRA-JEDNCBNOSA-N
InChI=1S/C6H14N2O2.C2H4O2/c7-4-2-1-3-5(8)6(9)10;1-2(3)4/h5H,1-4,7-8H2,(H,9,10);1H3,(H,3,4)/t5-;/m0./s1
DescriptionSources: https://www.nap.edu/read/10490/chapter/12Curator's Comment: description was created based on several sources, including
https://www.drugs.com/npp/lysine.html | https://www.ncbi.nlm.nih.gov/pubmed/26252373
Sources: https://www.nap.edu/read/10490/chapter/12
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/npp/lysine.html | https://www.ncbi.nlm.nih.gov/pubmed/26252373
Lysing is an essential basic amino-acid encoded by codone AAA and AAG, and used in the biosynthesis of proteins. The daily requirement for lysine is 38 mg/kg body weight. The most rich source of lysine is fish, beef, chicken. In a clinical study lysine supplements was found to be an effective for reduction of occurrence, severity and healing time for recurrent HSV infection, however Cochrane Review concluded that the evidence is insufficient. Lysine was investigated for improving anxiety, ameliorating angina prectoris. Lysine acetylsalicylate has been used to treat pain and to detoxify the body after heroin use. Lysine clonixinate has been used for its analgesic properties for the treatment of migraine headaches and other painful conditions. However, limited clinical trials exist for these conditions.
CNS Activity
Originator
Sources: https://www.drugs.com/npp/lysine.html
Curator's Comment: Lysine was first isolated from casein (a milk phosphoprotein) in 1889 by the German dentist Heinrich Drechsel
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1875 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28103616 |
|||
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8587651 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | L-LYSINE MONOHYDRATE Approved UseLysine has been studied for the prevention and treatment of herpes infections and cold sores. |
|||
Primary | L-LYSINE MONOHYDRATE Approved UseLysine supplements may relieve effort-related angina pectoris. |
|||
Sources: https://www.drugs.com/npp/lysine.html |
Primary | L-LYSINE MONOHYDRATE Approved UseLysine increases the intestinal absorption and reduces the renal elimination of calcium. |
||
Sources: https://www.drugs.com/npp/lysine.html |
Primary | L-LYSINE MONOHYDRATE Approved UseLysine is believed to exert anxiolytic effects by acting as a partial serotonin receptor 4 antagonist and as a partial benzodiazepine agonist |
||
Palliative | L-LYSINE MONOHYDRATE Approved UseLysine acetylsalicylate has been used to detoxify the body after heroin use. |
|||
Primary | NEOPROFEN Approved UseNeoProfen is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conducted among infants with an asymptomatic PDA. However, the consequences beyond 8 weeks after treatment have not been evaluated; therefore, treatment should be reserved for infants with clear evidence of a clinically significant PDA. Launch Date2006 |
PubMed
Title | Date | PubMed |
---|---|---|
Antibodies to SOX13 (ICA12) are associated with type 1 diabetes. | 2001 |
|
The antioxidant system beta-D(+) glucose-glucose oxidase-catalase: tests for pyrogenicity and antigenicity. | 2001 |
|
A systematic approach to the analysis of protein phosphorylation. | 2001 Apr |
|
Formation of 1,1'-iminodicarboxylic acid derivatives, 2,6-diketo-piperazine and dibenzodiazocine-2,6-dione by variations of multicomponent reactions. | 2001 Apr |
|
Translational extracts active biologically in vitro obtained from eukaryotic monolayer cells: a versatile method for viral RNA studies. | 2001 Apr |
|
Effect of the degree of fatty acid unsaturation of rat heart mitochondria on their rates of H2O2 production and lipid and protein oxidative damage. | 2001 Apr 15 |
|
The number of morphological synapses between neurons does not predict the strength of their physiological synaptic interactions: a study of dendrites in the nematode Ascaris suum. | 2001 Apr 16 |
|
Properties of microtubules assembled from mammalian tubulin synthesized in Escherichia coli. | 2001 Apr 17 |
|
Peflin and ALG-2, members of the penta-EF-hand protein family, form a heterodimer that dissociates in a Ca2+-dependent manner. | 2001 Apr 27 |
|
Ethanol production from wheat straw hemicellulose hydrolysate by Pichia stipitis. | 2001 Apr 27 |
|
Biochemical and functional characterization of a molecule expressed by a subset of thymic medullary epithelial cells. | 2001 Feb |
|
Isolation of the Escherichia coli nucleoid. | 2001 Feb |
|
Detection of early gene expression changes during activation of human primary lymphocytes by in vitro synthesis of proteins from polysome-associated mRNAs. | 2001 Feb |
|
The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. | 2001 Feb |
|
In vivo distribution and speciation of [114mIn]InCl3 in the Wistar rat. | 2001 Feb |
|
L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats. | 2001 Feb |
|
Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. | 2001 Feb |
|
How does endotoxin trigger inflammation in otitis media with effusion? | 2001 Feb |
|
Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line. | 2001 Feb |
|
Identification of novel hypocholesterolemic peptides derived from bovine milk beta-lactoglobulin. | 2001 Feb 16 |
|
Identification of a candidate integrin-fraction associated with the activated form of the PDGF-receptor. | 2001 Feb 23 |
|
Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. | 2001 Feb 6 |
|
Endotoxemia and acute-phase proteins in major abdominal surgery. | 2001 Jan |
|
Influence of lysates of the salivary glands of Lutzomyia longipalpis on the development of a Leishmania-major-like parasite in the skin of the golden hamster. | 2001 Jan |
|
ESR detection of intraphagosomal superoxide in polymorphonuclear leukocytes using 5-(diethoxyphosphoryl)-5-methyl-l-pyrroline-N-oxide. | 2001 Jan |
|
Inhibition of the nitrosothiol production of cultured osteoarthritic chondrocytes by rhein, cortisol and diclofenac. | 2001 Jan |
|
Continuous cell introduction for the analysis of individual cells by capillary electrophoresis. | 2001 Jan 1 |
|
A single-chain variable region immunoglobulin library from the abomasal lymph node of sheep infected with the gastrointestinal nematode parasite Haemonchus contortus. | 2001 Jan 26 |
|
Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii. | 2001 Jan 5 |
|
Panaxagin, a new protein from Chinese ginseng possesses anti-fungal, anti-viral, translation-inhibiting and ribonuclease activities. | 2001 Jan 5 |
|
Purification of recombinant green fluorescent protein using chromatofocusing with a pH gradient composed of multiple stepwise fronts. | 2001 Jan-Feb |
|
The function of interdomain interactions in controlling nucleotide exchange rates in transducin. | 2001 Jun 29 |
|
Endogenous formation of protein adducts with carcinogenic aldehydes: implications for oxidative stress. | 2001 Jun 29 |
|
Chemical and biological evaluation of endotoxin contamination on natural rubber latex products. | 2001 Jun 5 |
|
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA. | 2001 Mar |
|
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. | 2001 Mar 1 |
|
XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. | 2001 Mar 1 |
|
Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles. | 2001 Mar 1 |
|
Inositol phosphates from barley low-phytate grain mutants analysed by metal-dye detection HPLC and NMR. | 2001 Mar 1 |
|
Effects of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder. | 2001 Mar 14 |
|
Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. | 2001 Mar 15 |
|
High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin. | 2001 Mar 20 |
|
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. | 2001 Mar 21 |
|
Western blotting as a method for studying cell-biomaterial interactions: the role of protein collection. | 2001 Mar 5 |
|
Influence of crystal shape on the tableting performance of L-lysine monohydrochloride dihydrate. | 2001 May |
|
Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. | 2001 May 11 |
|
Isolation and characterization of senescence-induced cDNAs encoding deoxyhypusine synthase and eucaryotic translation initiation factor 5A from tomato. | 2001 May 18 |
|
CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. | 2001 May 25 |
|
The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases. | 2001 May 4 |
|
Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. | 2001 May 4 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.nap.edu/read/10490/chapter/12
Lysin is an essential amino-acid. The daily requirement for lysine is 38 mg/kg body weight. The most rich source of lysine is fish, beef, chicken.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28103616
In the in vitro study of herpes simplex virus (HSV) growth in tissue culture, arginine deficiency suppressed HSV growth. Maximum herpes growth (as measured by plaques counting) was observed in flasks, containing 10-20 ug/ml of arginine. The addition of 50 ug/ml of lysine to the flasks containing 2.5 and 5.0 ug/ml of arginine reduced the number of viable plaque-forming units (PFU) from 3300 and 48800 to less than 10.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
TTL6G7LIWZ
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
SUB127497
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104640
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
100000091744
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
DBSALT001763
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
TTL6G7LIWZ
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
104152
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
1371501
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
260-664-4
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
6537
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | RxNorm | ||
|
4453
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
57282-49-2
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
SUB127496
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
SUB21782
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
C66045
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY | |||
|
DTXSID80886223
Created by
admin on Fri Dec 15 15:20:00 GMT 2023 , Edited by admin on Fri Dec 15 15:20:00 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD